IXICO plc (AIM:IXI)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 13.33
-1.17 (-8.07%)
Nov 6, 2026, 3:36 PM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 29.19 million as of November 6, 2026. It is the 31,030th most valuable company in the world and the 687th biggest in the United Kingdom. Its market cap has increased by 179.99% in one year.
Market Cap
29.19M
Enterprise Value
28.07M
Revenue
7.28M
Global Rank
Country Rank
#687 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 29.19M, an increase of 230.87%. That is a compound annual growth rate of 9.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 29.19M | 168.07% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4basebio | 77.69M |
| Faron Pharmaceuticals Oy | 62.99M |
| Ondine Biomedical | 52.19M |
| Poolbeg Pharma | 48.22M |
| Hemogenyx Pharmaceuticals | 43.52M |
| Arecor Therapeutics | 37.37M |
| Sareum Holdings | 25.36M |
| ImmuPharma | 22.01M |